AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,893,055 | -2.9% | 84,319 | -0.2% | 0.66% | +2.0% |
| Q2 2023 | $6,069,942 | +16.8% | 84,469 | +0.3% | 0.65% | +6.1% |
| Q1 2023 | $5,194,751 | -20.3% | 84,221 | -0.4% | 0.61% | -24.2% |
| Q4 2022 | $6,521,342 | +325967.1% | 84,550 | +162496.2% | 0.80% | – |
| Q3 2022 | $2,000 | – | 52 | +477.8% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 9 | -93.7% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | 0.0% | 143 | -4.7% | 0.00% | 0.0% |
| Q4 2021 | $6,000 | -53.8% | 150 | -62.5% | 0.00% | -66.7% |
| Q3 2021 | $13,000 | -78.7% | 400 | -55.6% | 0.00% | -78.6% |
| Q2 2021 | $61,000 | +19.6% | 900 | 0.0% | 0.01% | +27.3% |
| Q1 2021 | $51,000 | -30.1% | 900 | 0.0% | 0.01% | -38.9% |
| Q4 2020 | $73,000 | +46.0% | 900 | +28.6% | 0.02% | +28.6% |
| Q3 2020 | $50,000 | +1150.0% | 700 | +821.1% | 0.01% | +600.0% |
| Q1 2020 | $4,000 | -90.2% | 76 | -81.0% | 0.00% | -85.7% |
| Q4 2019 | $41,000 | +310.0% | 400 | 0.0% | 0.01% | +250.0% |
| Q2 2019 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |